Company intelligence / Profile preview

Diapharm

Münster, Germany

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Diapharm is an international healthcare consulting and service provider focused on regulatory affairs, quality management, and business development for medicinal products, medical devices, food supplements, and cosmetics. It does not internally develop or market therapeutic drugs, but provides services particularly in regulatory, analytical, and quality fields across pre-approval and post-approval stages.[1][2][3][4]

Industry: Consulting

Partnerships

Tentamus Group

Beyond the preview

Go deeper on Diapharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diapharm.

Explore the full profile